Grace Chan

Dr. Grace Chan is an Associate Professor in the Department of Pediatrics at the Perelman School of Medicine, University of Pennsylvania. Her work bridges clinical pediatrics and epidemiology, with a focus on improving maternal and child health outcomes globally. She conducts research across multiple countries including Ethiopia, India, Bangladesh, and Indonesia, collaborating with international organizations such as the World Health Organization and Save the Children.

Research Interests: Dr. Chan specializes in pediatric and perinatal epidemiology, with a strong emphasis on infectious diseases, antimicrobial resistance, neonatal sepsis, and evidence-based interventions like kangaroo mother care. Her research leverages large longitudinal cohorts and implementation science to inform public health policy and clinical practice in low- and middle-income countries.

Publication Trends: Her recent publications reflect a consistent focus on neonatal health, antimicrobial resistance, and scalable interventions. Using data from multi-country cohorts, she investigates the etiology of neonatal infections, resistance patterns, and strategies for improving survival among preterm and low-birth-weight infants. Her work has directly influenced WHO guidelines and national health policies.

Scientific Contributions and Recognition: While specific awards are not listed, her research has had significant policy impact, including shaping WHO recommendations for neonatal sepsis treatment and promoting kangaroo mother care at scale in Ethiopia and India.

Mentorship and Grants: Dr. Chan has trained healthcare workers, researchers, and policymakers across Africa and South Asia. She has mentored numerous students and fellows, contributing to capacity building in global health research. Her projects involve major funding and collaborative networks, including the BARNARDS Group, supporting large-scale observational and intervention studies.

Labs and Teams: She leads and collaborates with international research teams, including the BARNARDS Group, focused on neonatal infections and antimicrobial resistance. Her work integrates data science and epidemiological methods within global health implementation frameworks.